• Skip to primary navigation
  • Skip to main content
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • Contact

GLWL Research Inc.

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • Contact
glwl pharma

GLWL Research Inc.

Investment: 2014
Visit Website

GLWL Research Inc.
Suite 2900
1000 Rue De La Gauchetiere Ouest
Montreal, Quebec H3B4W5
Canada

GLWL Research Inc., based in Montreal, Quebec, is a special purpose company created to develop one compound. The project is fully financed by TVM Life Science Innovation I L.P.. To date GLWL-01 has completed non-GLP tox studies and is poised to begin GLP tox studies and file an Investigational New Drug (IND) application in Q1-2015.

If the IND is approved, GLWL-01 will be tested in single ascending dose study in healthy male volunteers and, if appropriate, in a multiple ascending dose study eventually leading to a clinical proof of concept (POC) in T2DM patients. GLWL Research Inc. is funded by TVM Life Science Innovation I L.P. and is led by an experienced management team.

  • in

Copyright © 2021 · TVM Capital Life Science Venture Capital · Privacy Policy · Contact